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An education intervention to improve
health literacy and decision making about
supporting self-care among older
Australians: a study protocol for a
randomised controlled trial
Caroline A. Smith1*, Esther Chang2, Gisselle Gallego3 and Lynda G. Balneaves4

Abstract
Background: Older Australians are high consumers of complementary and alternative medicines (CM). To help
older people to take an active role in their health, we will develop and evaluate a novel educational intervention to
support decision self-efficacy, and improve health literacy skills.
Methods: The primary hypothesis is that participants receiving a web/DVD plus booklet intervention compared
with a booklet-only group will demonstrate an increase in decision self-efficacy. This study is a randomised
controlled trial. One hundred and sixty-eight people aged 65 years and older will be recruited from community
settings comprising retirement villages and community groups, based in Sydney, Australia. Participants will be
randomly allocated to either the education intervention delivered by the Internet or a DVD plus booklet versus a
control group (booklet only). The primary outcome measure is CM decision self-efficacy. Secondary outcomes are
health literacy, knowledge and attitudes, and change in health-seeking behaviour. Participants’ views on the ease of
using the resources, the length of the modules, the amount of information, and participant understanding of the
modules will be assessed. Outcomes will be collected on completion of the intervention at 3 weeks, and at a 2month follow up from trial entry.
Discussion: This trial has the potential to improve CM health literacy in older Australians. There are no educational
resources designed to support decision self-efficacy and improve health literacy amongst older people related to CM.
Trial registration: Australian New Zealand Clinical Trials Registry (ANZCTR), ACTRN12616000135415. Registered on 5
February 2016.
Keywords: Complementary medicine, Randomised controlled trial, Health literacy, Australia

Background
More than three million Australians (14% of the population) are aged over 65 years [1]. Studies indicate seniors
take an active role in their health care to improve their
health and wellbeing [2], and there is growing evidence that
seniors are high users of complementary medicines (CMs).
A survey of older Australians found 58% of those aged over
* Correspondence: caroline.smith@westernsydney.edu.au
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65 years have used at least one of 17 common CM modalities in a previous 12-month period, and 65% of these had
visited a CM provider [3]. The Australian Longitudinal
Study of Aging, an ongoing prospective study of the older
population, demonstrated the prevalence of CM utilisation
to have increased over time, from 17% in 2000–2001 to
35% in the 2003–2004 period [4]. CM is generally used to
treat a wide range of chronic health complaints that become increasingly common with age [5], particularly
musculo-skeletal conditions and pain [6], and anxiety or depression [7]. CM users report significant benefits to both
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their physical and mental health from CM [8, 9], and that
CM is highly valued by encouraging individuals to participate in their health [10].
To be health literate implies having a range of skills and
knowledge about health and health care, including the
ability to find, understand, interpret, and communicate
health information, seek appropriate care, and make critical health decisions [11]. Systematic reviews have concluded that low levels of health literacy are associated with
poorer treatment outcomes, including poor compliance
with medication, increased admissions to emergency departments, lower ability to interpret labels and health
messages, reduced health status, and increased mortality
among the elderly [12]. The ability to obtain reliable
health information is important to all populations but particularly older people. Reports indicate an increasing number of older people are seeking information on the
Internet [13], yet remain unaware of how to identify quality information to guide their use of this information.
There has been significant discussion in the literature
about what constitutes health literacy and how to measure
it. The health literacy Ophelia Project undertaken at Deakin
University, Australia, identified nine concepts of health literacy [14]. These include having sufficient information to
manage health, social support for health, skills to appraise
health information, ability to engage with healthcare providers, capacity to navigate the healthcare system, ability to
find good health information, and sufficient understanding
of health information to know what to do with it.
Complementary medicine may offer a way for older
people to cope with their ill health, or to engage in maintaining their health; however, this assumes good health literacy skills. There has been little research examining the
decision self-efficacy of CM users and their levels of health
literacy. This could be of particular concern due to the use
of CM without adequate supervision by a qualified health
practitioner, and a higher prevalence of polypharmacy
arising from the treatment of complex chronic health conditions [15]. Seniors may also be more susceptible to
medication sensitivity due to less optimal organ function
associated with aging [15–17]. Together, these concerns
may increase the risk of potential CM-drug interactions.
In the Australian community, the prevalence of serious
adverse reactions to CM is relatively low compared to
pharmaceutical medications [18]; however, mild reactions
are common. A retrospective review of previously collected health data identified that 15% of 5052 participants
used CM and 5.8% were identified as having a significant
risk of an adverse reaction [19]. These risks were linked to
garlic and ginkgo biloba and their interactions with drugs
affecting blood coagulation, such as aspirin and warfarin,
which, represented 95% of the (potential) significant interactions identified. Other high-risk natural product and
drug combinations identified as potentially dangerous
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include ginseng and warfarin, and St John’s wort used
along with digoxin.
This risk of interactions is further complicated by limited disclosure of CM use between consumers and their
healthcare providers. Non-disclosure rates to healthcare
providers among those using CM have been reported to
be as high as 71% [18, 20]. There are multiple reasons
for non-disclosure including the individual forgetting to
mention CM use, disclosure not being seen as relevant,
the doctor not asking about CM use, and the doctor not
respecting the value of CM [20]. Disclosure and communication about CM is essential for achieving optimal
treatment outcomes.
To explore these issues, we recently completed a twophase, sequential, mixed-method study incorporating
quantitative and qualitative methods to examine CM
health literacy in a population of older Australians living
in retirement villages [21]. We found older Australians
using CM were making decisions regarding managing
their own health and self-care [21]. Our primary findings
suggest this population demonstrate differing competencies relating to health literacy. We identified three scales
where older adults scored low including navigating the
health care system, an ability to find good information,
and appraisal of health information. Interpretation of
these scales suggests that some participants were unable
to understand most health information and were confused when they were presented with conflicting information. We found that these seniors were also unable to
access health information when required, they were frequently dependent on others to offer information, were
unable to advocate on their own behalf, and struggled to
find someone who could help them to use the healthcare
system to address their health needs.
There are few programmes that have addressed the specific health literacy needs of older people. A pilot health literacy programme that aimed to build health information
literacy skills found that following literacy workshops, participants were empowered to ask questions and reported
greater success with finding health information online [22].
Based on our study findings we have developed an
educational intervention to increase older adults’ skills
and ability to identify good and reliable sources of CM
information, resolve conflicting information, and access
a diverse range of current CM information sources that
can be used to guide their CM decisions with their
healthcare providers. The aim of this study is to determine the effectiveness of the CM educational intervention to increase older adults’ health literacy and decision
self-efficacy. Improved CM health literacy will enhance
appropriate use of health services and ultimately enable
older Australians to engage in taking an active role in
their health, and reducing the potential for adverse
health outcomes.
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Methods/designs
The primary hypothesis is that participants receiving a
web/DVD plus booklet intervention compared with a
booklet-only group will demonstrate an increase in decision self-efficacy. The secondary hypotheses are that participants receiving a web/DVD plus booklet intervention
compared with a booklet-only group will demonstrate
an increase in health literacy, communication skill, and
change in health-seeking behaviour.
Study design

This study (see Fig. 1) is a parallel, randomized, controlled trial of a CM education intervention delivered
online (using a purpose built website) or DVD plus
booklet versus a control group (booklet only) to examine
the effect on decision self-efficacy, health literacy, perception of risk, and health-seeking behavior, on completion of the intervention at 3 weeks, and at 2-month
follow up from trial entry. Full details of reporting of the
trial protocol items can be found in the “Standard protocol items: recommendation for interventional trials”
(SPIRIT) checklist (please see Additional file 1).
Trial setting

We will recruit participants from a community setting
comprising retirement villages and community groups,
based in Sydney, Australia. In Australia, a retirement village is made up of housing for people aged over 55 years
who are able to live independently. Many of these villages offer some healthcare services, leisure facilities,
and social clubs. The village provides smaller, manageable housing, supportive of the changing needs of older
people. In this setting, we will contact the managers of
the retirement villages to describe the study and seek
permission to come and promote the study to residents.
We will also recruit from various community groups, including senior citizen clubs, associations and referrals
from study participants.

Fig. 1 Schematic illustration of the research design

Study population

The study population will comprise men and women
aged 65 years and older, with access to the Internet or a
DVD player or computer, who will provide informed
consent for participation in the study. Exclusion criteria
include being unable to communicate in English or living in a long-term care facility.

plus booklet, or group 2: control booklet only (see Fig. 1).
Participants are not blind to their group allocation; however, the study analyst will be blind during analysis, and
the codes will be broken following statistical analysis.
The trial co-ordinator was not blind to study group.
Sample size calculation

Randomisation and blinding

The randomisation sequence was computer generated
by an online randomisation service by Sealed Envelope
randomisation service, Ltd 2016 (https://www.sealedenvelope.com/), with the codes concealed in sealed, opaque
envelopes. Participants will be randomised in a 1:1 ratio,
in blocks of eight to either group 1: web/DVD resource

The sample size was calculated using GPower, and was
based on “sample size effect” drawn from published data
[23]. It was estimated that a moderate effect size would
be obtained (i.e. Cohen D = 0.5) for the primary endpoint only, with improved decision self-efficacy between
groups at the end of the 3-week intervention. With the
alpha value set at 0.05 and power at 0.8 (i.e. 80% chance
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that the expected effect size would be significant), a
minimum sample size of 64 per group, with rounding to
70 per group was estimated. Allowing for 20% attrition,
a total sample size of 168 participants was required for
this trial (i.e. 84 per group).
Interventions

The educational intervention has been informed by our
preliminary research [21]. The delivery of the intervention
will comprise a multi-media (web/DVD) intervention, and
booklet. The delivery format has been informed by findings from the Cochrane systematic review of multimedia
educational interventions and offers advantages over the
traditional information delivery [24]. A combination of
audio with video or graphical presentation can overcome
difficulties with low literacy skills [25]. Studies have also
shown that learning is improved when material is presented as an audio-visual rather than visual-alone format
[26, 27]. A multimedia format also has the advantage that
the resources can be used at a pace that suits the user, and
at a time and place that is convenient to the individual.
The education intervention comprises five modules, and
includes information about CM and other self-care practices, such as exercise. The intellectual content of the intervention has been developed from the Complementary
Medicine Education and Outcomes (CAMEO) research
programme [28], and modified for use in the Australian
context. The CAMEO resource comprises a website and
booklet and was developed with links to credible and
evidence-based information resources (www.cameoprogram.org/). The CAMEO resource was developed for patients
with cancer; however, for this study the education resources
have been adapted for use with older individuals.
Group 1: DVD/web format

The intervention comprises five modules:
1. Module 1 - Complementary medicine - the evidence.
This module provides scientific evidence related to
the health benefits of CM, its indications, and details
of various evidence-based CM that are widely practiced globally.
2. Module 2 - Finding and evaluating complementary
medicine evidence. This module provides an
introduction to scientific evidence and how to find
research-based studies about CM. It describes databases that are available to find research, how to conduct a search, and how to use the available evidence
in making an informed choice about CM.
3. Module 3 - Decision making – complementary
medicine. In this module, advice is provided
regarding how to bring together the information
they have obtained from earlier modules, aligning
this with their goals and values, and how to have
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discussions with relevant key people to make an
informed decision about the use of CM. The
universally employed situation, choices, objectives,
people, evaluation, and decisions (SCOPED)
framework [29] has been incorporated to assist the
participant in their decision making.
4. Module 4 - Working with complementary medicine
practitioners. This module explains the role of
conventional healthcare providers and CM
practitioners, and the importance of, and how to
disclose CM use with conventional health providers.
Guidance is provided regarding the regulatory frame
work for CM practitioners in Australia, how to find
a professionally accredited CM practitioner and
practical tips and questions to ask to guide the
selection of a CM practitioner.
5. Module 5 - Monitoring complementary medicine
decisions. This module explains the need to monitor
one’s health following the use of CM products or
therapies. It provides guidance on certain criteria
that should be utilised in respect to monitor one’s
health and the safety of CM and the procedure
(including contact details) of adverse events
reporting for CM therapy and services in Australia.
There is a final section that includes two case
studies of individuals exploring self-care and use of
CM that draws on the detailed information presented in the modules.
Participants in the intervention group will be invited to
watch the five-module intervention in their home by either accessing a website using a password, or viewing a
DVD player or computer, over a 3-week time period. Each
module takes approximately 30 minutes to complete, and
completion of two modules per week over 3 weeks is recommended. Users will be able to pace their learning using
the navigation menus on the website or DVD. Participants
are able to access the intervention as often as they wish.
They will also receive a copy of the booklets.
Group 2: control group

The active control group comprises two booklets including summarised content from modules one, three, five
and the case studies. The content focuses on presenting
information on evidence-based CM modalities, guidance
to sourcing reliable CM information, how to make decisions about evidence-based CM, why it is important to
monitor and evaluate the use of CM, and details about
how to discuss CM use with your healthcare provider. A
second booklet provides written examples of the two
case studies, and applying the information into practice.
The booklet text is written in 18-point Arial font and at
a 6th-grade reading level. Paced reading is encouraged
over the 3-week intervention.

Smith et al. Trials (2017) 18:441

Development and piloting of the intervention

The investigators undertook development, proofing and
editing of the web materials and booklet, with the assistance of web and communication officers at Western Sydney University. Following development of the modules
and booklet, a pilot study was undertaken for preliminary
testing of the educational and assessment tools. Four participants were presented with the booklet or access to the
website to review the booklet or selected web-based modules. Participants were requested to read the allocated resources and to complete a short feedback form on the
content of the resources, ease of understanding the material, did they feel overwhelmed by the amount of content,
did the images help them to engage with the material, was
the font size and layout appropriate, and was the website
easy to navigate? The participants were also invited to
come together in a focus group context to discuss the resources. The group session was led by GG and the interview guide included questions about ease of use of the
educational materials (i.e. font size, colour, background,
instructions), and how long it took participants to
complete the modules. For those using the website specific
questions were asked about where they accessed the website, and what did they use (i.e., tablet, laptop, desktop).
Participants were also asked about the ease of understanding the concepts presented.
Feedback from the focus groups indicated participants
found the information useful and interesting, they
enjoyed the interactive, engaging and colourful format of
the resources, the modules did not require as much time
as expected to complete, and they enjoyed accessing the
resources in their own time. The baseline questionnaire
was also pilot tested with the focus group and as a result
small wording and skip logic changes were undertaken
to the instruments.
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they are continuing to access the resources and address
any difficulties. Primary and secondary outcome data
will be collected at baseline, at the end of the intervention and at two months from trial entry. At trial entry
we will collect baseline data on socio-demographic (age,
gender, place of birth, education status, employment status, ethnicity, English skills, Medicare and private health
insurance) and health characteristics, health behaviour,
and lifestyle including CM use, sources of information,
Internet skills, health literacy status, and decisionmaking (Fig. 2: SPIRIT figure).
Data management

Data capture will be via paper-based questionnaires.
Data will be manually entered onto the electronic REDCap data management system by the trial co-ordinator.
Any issues will be discussed at the weekly research
meeting. All entered data will be de-identified.
Primary outcome measure
Decision self-efficacy

The primary outcome is the change on decision selfefficacy at the end of the intervention assessed between
groups. The Decision Self-Efficacy scale [30] will be used
to assess differences in decision-making skills. The Decision Self-Efficacy scale will measure self-confidence or
belief in one’s ability to make decisions, including an
ability to participate in shared decision making. This
scale comprises 11 items rated along a 5-point scale
from “not at all confident” to “very confident”. The psychometric properties report an alpha coefficient of 0.92,
and the scale has been shown to be correlated with decisional conflict scales (DSC) of feeling informed (0.47)
and supported (0.45) [32]. Scores on the scale are converted to a 0–100 scale. Scores range from 0 (extremely
low self-efficacy) to 100 (extremely high self-efficacy).

Procedure for the trial

Following completion of the pilot and minor modification to the resources, recruitment for the main trial
commenced in July 2016. Recruitment will be undertaken at all interested retirement villages. Study promotion will involve letter box drops, and promotional talks
by the investigators and the trial co-ordinator. At these
visits, following a promotional study presentation, expressions of interests will be gathered and participant information and consent forms made available. A mutually
convenient time will be made to obtain informed consent and to complete baseline questionnaires.
Following randomisation, the trial co-ordinator will
meet with each participant to ensure they are able to access the website using the password and to navigate the
modules, or ensure navigation with the DVD is satisfactory. To minimise attrition, all groups will receive a
phone call mid-way through the intervention to ensure

Secondary outcome measures

The preparation for the decision-making scale assesses a
participant’s perception of how useful a decision aid or
other decision support intervention is in preparing the
individual to communicate with their practitioner at a
consultation focused on making a health decision [31].
The scale addresses concepts of preparedness for decision making and consists of 10 items rated along a 5point scale from “not at all” to “a great deal”. This scale
has shown significant correlation with the informed (r =
− 0.21, p < 0.01) and support (r = − 0.13, p = 0.01) DSC
subscales [32], and discriminates significantly between
participants who did and did not find the decision aid
helpful (p < 0.0001). Alpha coefficients for internal
consistency ranged from 0.92 to 0.96. The scale is
strongly unidimensional and item response theory analyses demonstrated that all ten scale items perform well

Smith et al. Trials (2017) 18:441
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Fig. 2 Standard protocol items: recommendation for interventional trials (SPIRIT) schedule of enrolment, interventions, and assessments

[31]. The scale is only administered after the intervention has been administered, and the items are summed,
scored and converted to a 0–100 scale. Higher scores indicate a higher perceived level of preparation for decision making.
The health literacy of participants will be evaluated
using a validated and universally employed Health Literacy Questionnaire (HLQ) [14]. The HLQ contains a
total 55 questions grouped into nine domains including:
(1) feeling understood and supported by healthcare
providers; (2) having sufficient information to manage
personal health; (3) an ability to actively manage personal health; (4) social support for health; (5) appraisal
of health information; (6) ability to actively engage with
health care providers; (7) navigating the health care system; (8) ability to find good health information; and (9)
understanding health information well enough to know
what to do. Each scale includes four to five items, with
participants indicating their response along a Likerttype scale with response options ranging from 1 - “very
difficult” to 4 - “very easy”, or along a 5-point scale ranging from “strongly agree” to “strongly disagree.” The
HLQ has strong psychometric properties, it is grounded
in the individual’s lived experience, and is validity
driven [14]. Reliability testing was examined using Raykov’s procedures rather than Cronbach’s alpha where >
0.80 was sought. This was achieved for eight of the nine

domains; the lowest reliability estimates were achieved
for the appraisal of information (0.77). Health literacy
scales will be calculated using a scoring algorithm for
the HLQ version 1 (dated 2012). The algorithm produces unweighted scale scores for the nine scales of the
HLQ, with the final score for each subscale an average
score across all items forming the scale. For missing
values, this programme uses an algorithm to impute
missing values. For scales with four to five items, two
missing values can be imputed. For scales with six
items, three missing value can be imputed, and if more
responses among the scale items were missing, scale
score were not computed.
Health-seeking behaviour will be assessed by responses
to questions on use of self-care and CM. It will be
assessed through a self-reported questionnaire based on
questions relating to use of health information sources.
Perception of risk will ask questions about the safety of
CM. To evaluate the intervention we are seeking participants’ views on the ease of using the resources, the
length of the modules, the amount of information and
participant understanding of the modules and written
information. We will ask participants if they have used
the resources outside of the intervention, and if yes, how
easy or difficult this was, and did the resources assist
with making an informed decision. All data forms will
be completed by study participants.

Smith et al. Trials (2017) 18:441

Statistical analysis

The trial co-ordinator will co-ordinate all data management and cleaning prior to analysis. Data on refusal and
dropout will be coded and reported according to Consolidated Standards of Reporting Trials (CONSORT)
guidelines [33, 34]. A description of the baseline characteristics of study participants will be compiled using descriptive statistics, such as mean, standard deviation for
continuous variables and categorical variables will be
summarised by counts and percentages.
The primary analysis will be conducted using all randomised participants. The chi square (X2) test and analysis
of variance (ANOVA) will be used to identify the differences between intervention groups for the categorical and
continuous variables respectively. Secondary analyses will
examine changes within group over time using repeated
measures ANOVA and the Sidak test to correct for multiple comparisons [35]. Levels of significance will be reported at the p < 0.05 level. All CIs will contribute to data
interpretation. All analyses were conducted using SPSS
statistical software, version 22. The results from this unblended trial will be critically evaluated for bias, and this
will be considered during interpretation of the results.

Discussion
We have identified a need to support older adults’ decision
self-efficacy regarding CM. Low levels of health literacy
have also been identified among an older population of CM
users, who struggle to find good information, and understand what it means [21]. This trial seeks to improve decision making by providing information resources to
participants to understand why research studies are important, to seek out reliable information and apply new skills to
inform their decision self-efficacy. We aim to examine
changes in behaviour in the short term and believe these information resources have the potential to reduce the risk of
adverse events arising from mis-information.
We expect that this trial will contribute to our understanding of interventions aimed at supporting decision
self-efficacy regarding any self-care behaviour to maintain
health and wellbeing, including appropriate use of selfcare and CM in older Australians. In addition, by assessing the effect of the intervention on decision self-efficacy,
health literacy and health-seeking behaviour, and we will
gain new insights into the preferred method of delivery of
information resources to older Australians. The outcomes
from this study will be important given the high rates of
non-disclosure to health professions regarding CM use
and previously identified areas of low health literacy.
Dissemination

We plan to disseminate findings via an academic journal,
we will also write to all study participants and retirement
villages with a copy of the results. All reports will follow
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the CONSORT guidelines [36] and the extension to
non-pharmacological interventions [34]. We will follow
the NHMRC codes of conduct for research authorship.
The trial protocol will be made freely available. A reasonable request for de-identified data set will be considered by the investigators.
Trial status

Recruitment commenced in July 2016. Recruitment was
completed in May 2017, and the study was completed in
July 2017.

Additional file
Additional file 1: Spirit checklist. (DOC 120 kb)
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